2,4-Disubstituted 5-Nitroimidazoles Potent against Clostridium difficile

ChemMedChem. 2019 Mar 5;14(5):561-569. doi: 10.1002/cmdc.201800784. Epub 2019 Feb 5.

Abstract

Metronidazole is one of the first-line treatments for non-severe Clostridium difficile infections (CDI). However, resistance limits its use in cases of severe and complicated CDI. Structure-activity relationships previously described for the 5-nitroimidazole series have shown that functionalization at the 2- and 4-positions can impart better activity against parasites and anaerobic bacteria than metronidazole. Herein we report the synthesis of new 2,4-disubstituted 5-nitroimidazole compounds that show potent antibacterial activity against C. difficile. We used a vicarious nucleophilic substitution of hydrogen (VNS) reaction to introduce a phenylmethylsulfone at the 4-position and a unimolecular radical nucleophilic substitution (SRN 1) reaction to introduce an ethylenic function at the 2-position of the 5-nitroimidazole scaffold.

Keywords: Clostridium difficile; antibiotics; medicinal chemistry; nitrogen heterocycles; radical reactions.

MeSH terms

  • Animals
  • Anti-Bacterial Agents / chemical synthesis*
  • Anti-Bacterial Agents / pharmacology
  • CHO Cells
  • Cell Survival / drug effects
  • Clostridioides difficile / drug effects
  • Clostridium Infections / drug therapy*
  • Cricetulus
  • Drug Design
  • Drug Resistance, Bacterial / drug effects
  • Humans
  • Metronidazole / pharmacology
  • Molecular Structure
  • Nitroimidazoles / chemical synthesis*
  • Nitroimidazoles / pharmacology
  • Structure-Activity Relationship
  • Sulfones / chemistry

Substances

  • Anti-Bacterial Agents
  • Nitroimidazoles
  • Sulfones
  • Metronidazole